KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Raw Materials (2023 - 2025)

Thermo Fisher Scientific's Raw Materials history spans 10 years, with the latest figure at $1.9 billion for Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials rose 4.1% year-over-year to $1.9 billion, compared with a TTM value of $1.9 billion through Dec 2025, up 4.1%, and an annual FY2025 reading of $1.9 billion, up 4.1% over the prior year.
  • Raw Materials for Q4 2025 was $1.9 billion at Thermo Fisher Scientific, down from $2.0 billion in the prior quarter.
  • The five-year high for Raw Materials was $2.1 billion in Q4 2023, with the low at $1.8 billion in Q4 2024.
  • Average Raw Materials over 3 years is $1.9 billion, with a median of $1.9 billion recorded in 2025.
  • Year-over-year, Raw Materials fell 12.35% in 2024 and then grew 4.1% in 2025.
  • Tracing TMO's Raw Materials over 3 years: stood at $2.1 billion in 2023, then dropped by 12.35% to $1.8 billion in 2024, then increased by 4.1% to $1.9 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Raw Materials are $1.9 billion (Q4 2025), $2.0 billion (Q3 2025), and $1.9 billion (Q2 2025).